[Influenza vaccination in the elderly: effectiveness not in doubt]

Area of Science:

• Gerontology
• Epidemiology
• Immunology

Context:

• Recent reviews questioned influenza vaccine effectiveness in the elderly due to potential biases like selection bias and use of non-specific outcomes.
• Concerns were raised that vaccine benefits regarding morbidity and mortality might be overestimated.

Purpose:

• To evaluate the effectiveness of influenza vaccination in community-dwelling elderly persons, addressing potential biases and confounding factors.
• To provide reliable estimates of influenza vaccination's impact on influenza-related morbidity and mortality in the elderly.

Summary:

• Despite previous concerns, a recent study demonstrated that influenza vaccination significantly reduces influenza-related morbidity and mortality in community-dwelling elderly individuals, even after controlling for bias.
• Direct measurement of influenza-related morbidity was challenging due to diagnostic limitations; however, indirect estimates from excess studies consistently favored vaccination.
• The age limit for influenza vaccination in the Netherlands was lowered to 60 in 2008, reflecting increased understanding of influenza's impact on younger elderly individuals and vaccine efficacy.

Impact:

• Confirms the significant protective effect of influenza vaccination in the elderly population, reinforcing public health recommendations.
• Highlights the importance of addressing biases in observational studies to accurately assess vaccine effectiveness.
• Supports policy decisions, such as lowering the vaccination age, based on robust evidence of influenza's impact and vaccine benefits.